WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niikura, T.
Right arrow Articles by Nishimoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niikura, T.
Right arrow Articles by Nishimoto, I.

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 15, 2001, 21(6):1902-1910

Insulin-Like Growth Factor I (IGF-I) Protects Cells from Apoptosis by Alzheimer's V642I Mutant Amyloid Precursor Protein through IGF-I Receptor in an IGF-Binding Protein-Sensitive Manner

Takako Niikura1, Yuichi Hashimoto1, Takashi Okamoto2, Yoichiro Abe1, Takashi Yasukawa1, Masaoki Kawasumi1, Takako Hiraki1, Yoshiko Kita1, Kenzo Terashita1, Keisuke Kouyama1, and Ikuo Nishimoto1

1 Department of Pharmacology and Neurosciences, Keio University School of Medicine, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan, and 2 RIKEN Brain Science Institute, Hirosawa, Wako-shi, Saitama 351-0198, Japan

It has been found that insulin-like growth factor I (IGF-I) exerts cytoprotection against Abeta amyloid-induced neuronal cell death. Deposits of Abeta amyloid are one of the pathological hallmarks of Alzheimer's disease (AD). Here, we examined whether IGF-I exerts protective activity against cell death induced by a familial AD (FAD)-linked mutant of amyloid precursor protein (APP), and we found that IGF-I protected cells from toxicity of FAD-associated V642I mutant of APP in multiple cell systems. IGFBP-3 blocked this action of IGF-I, but not of des(1-3)IGF-I, which was as active as IGF-I in the presence of IGFBP-3. The data also demonstrated that the IGF-I receptor (IGF-IR) mediates the protective activity of IGF-I. The antagonizing function of the IGF-I/IGF-IR system against V642I-APP, which is further antagonized by IGFBP-3, provides a molecular clue to the understanding of AD pathophysiology and to the establishment of potential therapy for AD.

Key words: IGF-I; IGFBP; des(1-3)IGF-I; amyloid precursor protein; Alzheimer's disease; neuroprotection


Copyright © 2001 Society for Neuroscience  0270-6474/01/2161902-09$05.00/0


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Gomez-Brouchet, D. Pchejetski, L. Brizuela, V. Garcia, M.-F. Altie, M.-L. Maddelein, M.-B. Delisle, and O. Cuvillier
Critical Role for Sphingosine Kinase-1 in Regulating Survival of Neuroblastoma Cells Exposed to Amyloid-beta Peptide
Mol. Pharmacol., August 1, 2007; 72(2): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J Svensson, M Diez, J Engel, C Wass, A Tivesten, J-O Jansson, O Isaksson, T Archer, T Hokfelt, and C Ohlsson
Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice.
J. Endocrinol., June 1, 2006; 189(3): 617 - 627.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Endocr. Rev., December 1, 2005; 26(7): 916 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Carro, C. Spuch, J. L. Trejo, D. Antequera, and I. Torres-Aleman
Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I
J. Neurosci., November 23, 2005; 25(47): 10884 - 10893.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Hashimoto, O. Tsuji, K. Kanekura, S. Aiso, T. Niikura, M. Matsuoka, and I. Nishimoto
The Gtx Homeodomain Transcription Factor Exerts Neuroprotection Using Its Homeodomain
J. Biol. Chem., April 16, 2004; 279(16): 16767 - 16777.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. Shan, M. L. Messi, Z. Zheng, Z.-M. Wang, and O. Delbono
Preservation of motor neuron Ca2+ channel sensitivity to insulin-like growth factor-1 in brain motor cortex from senescent rat
J. Physiol., November 15, 2003; 553(1): 49 - 63.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ikonen, B. Liu, Y. Hashimoto, L. Ma, K.-W. Lee, T. Niikura, I. Nishimoto, and P. Cohen
Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis
PNAS, October 28, 2003; 100(22): 13042 - 13047.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Hashimoto, T. Niikura, T. Chiba, E. Tsukamoto, H. Kadowaki, H. Nishitoh, Y. Yamagishi, M. Ishizaka, M. Yamada, M. Nawa, et al.
The Cytoplasmic Domain of Alzheimer's Amyloid-{beta} Protein Precursor Causes Sustained Apoptosis Signal-Regulating Kinase 1/c-Jun NH2-Terminal Kinase-Mediated Neurotoxic Signal via Dimerization
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 889 - 902.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. Marshman, K. A. Green, D. J. Flint, A. White, C. H. Streuli, and M. Westwood
Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells
J. Cell Sci., February 15, 2003; 116(4): 675 - 682.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D Liolitsa, J Powell, and S Lovestone
Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, September 1, 2002; 73(3): 261 - 266.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Gurwitz, J. Chapman, and A. Weizman
Head circumference and incident Alzheimer's disease: Modification by apolipoprotein E
Neurology, May 14, 2002; 58(9): 1440 - 1440.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wei, X. Wang, and J. W. Kusiak
Signaling Events in Amyloid beta -Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection
J. Biol. Chem., May 10, 2002; 277(20): 17649 - 17656.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Hashimoto, T. Niikura, Y. Ito, H. Sudo, M. Hata, E. Arakawa, Y. Abe, Y. Kita, and I. Nishimoto
Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults
J. Neurosci., December 1, 2001; 21(23): 9235 - 9245.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Hashimoto, T. Niikura, H. Tajima, T. Yasukawa, H. Sudo, Y. Ito, Y. Kita, M. Kawasumi, K. Kouyama, M. Doyu, et al.
A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta
PNAS, May 22, 2001; 98(11): 6336 - 6341.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2010 by Society for Neuroscience ONLINE ISSN: 1529-2401
-